Endocrinology, Vol 132, 1132-1138, Copyright © 1993 by Endocrine Society

ARTICLES

Ligand-binding properties of the two isoforms of the human insulin receptor

Y Yamaguchi, JS Flier, H Benecke, BJ Ransil and DE Moller
Charles A. Dana Research Institute, Harvard-Thorndike Laboratory, Beth Israel Hospital, Boston, Massachusetts 02215.

Tissue-specific alternative splicing of exon 11 of the insulin receptor gene results in 2 mRNAs that differ by 36 nucleotides within the coding region. The 2 transcripts encode 2 protein isoforms with (Ex11+) or without (Ex11-) 12 additional amino acids at the carboxy-terminus of the receptor alpha-subunit. Previous studies of the 2 isoforms of the human insulin receptor expressed in mammalian cell transfectants have revealed small functional differences at the levels of equilibrium insulin binding affinity and acute ligand-induced receptor internalization. In the present study, we determined the biochemical basis for differential insulin binding affinity. Further functional characterization of the 2 receptor isoforms was also performed. The results obtained were as follows. 1) Studies of ligand association demonstrated a faster (1.8-fold) "on rate" for Ex11- receptors than for Ex11+ receptors, as determined by the kinetics of [125I]insulin binding to transfected cells. In addition, dissociation of prebound [125I]insulin from Ex11- receptors was characterized by an accelerated "off rate" relative to that of Ex11+ receptors. 2) Using both intact Chinese hamster ovary (CHO) cells and partially purified solubilized insulin receptors, the ability of insulin-like growth factor-I to compete for [125I]insulin binding to either isoform differed markedly. The mean IC50 for Ex11- was 40 nM vs. 350 nM for Ex11+. 3) Both Ex11- and Ex11+ receptors were equally capable of hybrid formation with endogenous CHO cell insulin-like growth factor-I receptors. 4) The relative abilities of 2 inhibitory polyclonal antiinsulin receptor antisera to displace [125I]insulin binding did not differ between the two isoforms. 5) Studies of insulin-induced (300 nM) receptor down- regulation in CHO cell transfectants suggested preferential down- regulation of Ex11- receptors; however, no down-regulation difference was observed when Rat 1 cell transfectants expressing the two splice variants were studied. These findings further support the idea that the 2 isoforms of the insulin receptor are functionally distinct in important ways.

This article has been cited by other articles:

				A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease Endocr. Rev., October 1, 2009; 30(6): 586 - 623. [Abstract] [Full Text] [PDF]

				A. E. Wahner Hendrickson, P. Haluska, P. A. Schneider, D. A. Loegering, K. L. Peterson, R. Attar, B. D. Smith, C. Erlichman, M. Gottardis, J. E. Karp, et al. Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro Cancer Res., October 1, 2009; 69(19): 7635 - 7643. [Abstract] [Full Text] [PDF]

				A. Sacco, A. Morcavallo, G. Pandini, R. Vigneri, and A. Belfiore Differential Signaling Activation by Insulin and Insulin-Like Growth Factors I and II upon Binding to Insulin Receptor Isoform A Endocrinology, August 1, 2009; 150(8): 3594 - 3602. [Abstract] [Full Text] [PDF]

				A. Navarrete Santos, N. Ramin, S. Tonack, and B. Fischer Cell Lineage-Specific Signaling of Insulin and Insulin-Like Growth Factor I in Rabbit Blastocysts Endocrinology, February 1, 2008; 149(2): 515 - 524. [Abstract] [Full Text] [PDF]

				A. Navarrete Santos, S. Tonack, M. Kirstein, S. Kietz, and B. Fischer Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos Reproduction, November 1, 2004; 128(5): 503 - 516. [Abstract] [Full Text] [PDF]

				J. Whittaker, H. Sorensen, V. L. Gadsboll, and J. Hinrichsen Comparison of the Functional Insulin Binding Epitopes of the A and B Isoforms of the Insulin Receptor J. Biol. Chem., November 27, 2002; 277(49): 47380 - 47384. [Abstract] [Full Text] [PDF]

				K. H. Surinya, L. Molina, M. A. Soos, J. Brandt, C. Kristensen, and K. Siddle Role of Insulin Receptor Dimerization Domains in Ligand Binding, Cooperativity, and Modulation by Anti-receptor Antibodies J. Biol. Chem., May 3, 2002; 277(19): 16718 - 16725. [Abstract] [Full Text] [PDF]

				J. Nakae, Y. Kido, and D. Accili Distinct and Overlapping Functions of Insulin and IGF-I Receptors Endocr. Rev., December 1, 2001; 22(6): 818 - 835. [Abstract] [Full Text] [PDF]

				F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo, A. Costantino, I. D. Goldfine, A. Belfiore, and R. Vigneri Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells Mol. Cell. Biol., May 1, 1999; 19(5): 3278 - 3288. [Abstract] [Full Text] [PDF]

				C. Kristensen, F. C. Wiberg, L. Schaffer, and A. S. Andersen Expression and Characterization of a 70-kDa Fragment of the Insulin Receptor That Binds Insulin. MINIMIZING LIGAND BINDING DOMAIN OF THE INSULIN RECEPTOR J. Biol. Chem., July 10, 1998; 273(28): 17780 - 17786. [Abstract] [Full Text] [PDF]

				S. L. Calzi, C. V. Choice, and S. M. Najjar Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E801 - E808. [Abstract] [Full Text] [PDF]

				P.-Y. Chang, L. J. Goodyear, H. Benecke, J. S. Markuns, and D. E. Moller Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors J. Biol. Chem., May 26, 1995; 270(21): 12593 - 12600. [Abstract] [Full Text] [PDF]